GSTP1 and breast carcinoma: 4) GSTP1 rs1695 was found to be related to therapeutic response and occurrence of adverse drug effect in chemotherapy of cancers such as gastric cancer [28], colorectal cancer [29], nonsmall cell lung cancer [30], ovarian cancer [31], esophageal cancer [32], and breast cancer [33].